• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Integrated 2D/3D mammography improves breast cancer detection

bys25qthea
April 27, 2013
in Chronic Disease, Obstetrics, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Compared to 2D mammography alone, integrated 2D and 3D mammography facilitated detection of more breast cancers in asymptomatic women. 

2. Less false positives occurred with integrated mammography than with conventional 2D mammography alone.   

Evidence Rating Level: 2 (Good) 

Study Rundown: This study found that integrated 2D and 3D mammography, or 2D mammography combined with digital breast tomosynthesis with 3D images, detected more breast cancers than 2D mammography alone and was associated with a lower incidence of false positive findings. These results are timely given recent investigations characterizing the problem of breast cancer overdiagnosis associated with population-level mammography screenings. Strengths of this investigation include a large sample size (n=7,292) and within-subject comparisons of mammography method that allowed each woman to serve as her own control. Future investigations might employ a randomized controlled design to evaluate the long-term effects of integrated mammography on morbidity and mortality.

Click to read the study in Lancet Oncology 

Relevant Reading: Overview of the evidence on digital breast tomosynthesis in breast cancer detection

RELATED REPORTS

#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers

#VisualAbstract: Metformin does not improve survival in patients with high-risk, nonmetastatic breast cancer

#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage

In-Depth [prospective comparative study].  This study assessed screening outcomes using integrated 2D and 3D mammography versus 2D mammography alone in a cohort of 7,292 asymptomatic Italian women at average risk for breast cancer (ages ≥48 years). Each participant received both 2D and 3D mammography. Outcomes included cancers detected, false positives, and incremental cancer detection.

Overall, integrated mammography yielded a detection rate of 8.1 per 1,000 screens (95% CI: 6.2-10.4) while 2D mammography alone provided a detection rate of 5.3 cancers per 1,000 screens (CI: 3.8-7.3, p<0.0001) such that the incremental improvement in cancer detection rate attributable to method was 2.7 cancers per 1,000 screens (CI: 1.7-4.2). False-positive findings were recorded in 2% (CI: 1.6-2.3) of patients with 2D mammography only and in 1% (CI: 0.8-1.3) of patients with integrated mammography (p<0.0001).

By Caroline Huang and Leah Hawkins

More from this author: One third of breast cancer survivors report pain 5-7 years after treatment, Varenicline reduces post-quit smoking relapses, Severe maternal childhood abuse associated with autism in offspring, 233 million women projected to lack modern contraceptives by 2015, Reminder intervention increases colorectal cancer screening rates, After-school program increases physical activity in overweight children, School-based therapy reduces asthma symptoms

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: Breast Cancermammography
Previous Post

Insurance status affects treatment of early stage breast cancer

Next Post

The PROVE IT trial: High-dose statin regimen reduces mortality after ACS [Classics Series]

RelatedReports

#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers
StudyGraphics

#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers

August 2, 2022
#VisualAbstract: Metformin does not improve survival in patients with high-risk, nonmetastatic breast cancer
StudyGraphics

#VisualAbstract: Metformin does not improve survival in patients with high-risk, nonmetastatic breast cancer

July 26, 2022
#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage
StudyGraphics

#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage

July 19, 2022
Choosing Wisely campaign releases recommendations in newborn medicine
Oncology

ERBB2-low tumours are not a distinct biologic or prognostic subgroup from ERBB2-0 tumour breast cancer.

July 11, 2022
Next Post

The PROVE IT trial: High-dose statin regimen reduces mortality after ACS [Classics Series]

Chromosomal analysis not cost-effective in evaluation of recurrent miscarriage

Chromosomal analysis not cost-effective in evaluation of recurrent miscarriage

Children with cancer exposed to home medication errors

Children with cancer exposed to home medication errors

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Management of uncomplicated urinary tract infections amongst women in the United States Military Health System highly concordant with guidelines
  • Gout flares associated with a transient increase in subsequent risk of cardiovascular events
  • Litifilimab associated with reduced disease severity in patients with cutaneous lupus erythematosus
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.